Skip Navigation
Toggle Navigation
Search:
Search Submit
Our
Company
About Us
Leadership
Management
Board of Directors
Scientific Advisory Board
Contact Us
Pipeline
Pipeline Overview
Therapeutic Areas
Inflammation
Oncology
Clinical Trials
Compassionate Use at Celldex Therapeutics
Science
Antibody-Based Therapeutics
Bispecific Platform
Publications
Investors
& Media
Investor & Media Home
Press Releases
Events & Presentations
Analyst Coverage
Financials & Filings
SEC Filings
Quarterly Results
Annual Reports & Proxies
Corporate Governance
Documents & Charters
Management
Board of Directors
Scientific Advisory Board
Committee Composition
Investor Resources
Contact Us
Email Alerts
Careers
Contact Us
Search:
Search Toggle
Science
Keler et al
,
SITC 2013 Poster
, November 2013
"Combination Therapies Augment the Anti-Tumor Activity of Agonist CD27 mAb in Human CD27 Transgenic Mouse Models"
Learn More
';